1.
Australas J Dermatol
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38439213
RESUMO
We present a palmoplantar pustulosis case partially resistant to systemic IL-17A inhibitor (ixekizumab) treatment, and then receiving a local injection of 0.1 mL micro-dose (1 mg) IL-23 inhibitor (guselkumab) every 4 weeks for four times. The paradoxical lesion disappeared rapidly following local injection and there was no recurrence after 8 weeks of drug withdrawal. This is the first clinical report on the treatment of palmoplantar pustulosis by local injection of micro-dose guselkumab.
2.
3.
Int J Dermatol
; 63(4): 547-548, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38228398